JONATHAN RUSSELL: Open Payments
NPI 1396934196 · WINSTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 14 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $483 · 2025 $449
Food & beverage: $433Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $147 |
| Amgen Inc. | 1 | $62 |
| E.R. Squibb & Sons, L.L.C. | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| ABBVIE INC. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Exact Sciences Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
Products named: FARXIGA, COBENFY, TRELEGY ELLIPTA, AIRSUPRA, MAVYRET, CAPLYTA, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across OR — which companies pay providers there.
